Statistiques de base
| CIK | 1839730 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Skylight Health Group Inc
SEC Filings (Chronological Order)
Cette page fournit une liste complète et chronologique des documents déposés auprès de la SEC, à l'exclusion des documents relatifs à la participation que nous fournissons ailleurs.
| September 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-40414 SKYLIGHT HEALTH GROUP INC. (Exact name of registrant as specified |
|
| September 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-40414 SKYLIGHT HEALTH GROUP INC. (Exact name of registrant as specified |
|
| August 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of |
|
| August 24, 2022 |
EXHIBIT 99.1 Skylight Health Provides Clinical Research Update Skylight Health Research continues to see success and trial awards TORONTO, Aug. 24, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG;TSXV:SLHG) (?Skylight Health? or the ?Company?), a healthcare platform combining technology, and analytics focused on transitioning patients into value based care to drive better health ou |
|
| August 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of |
|
| August 17, 2022 |
Skylight Health Announces Closing of Convertible Debenture Financing EXHIBIT 99.1 Skylight Health Announces Closing of Convertible Debenture Financing TORONTO, Aug. 17, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, is pleased to announce that it has closed the non-brokered private placement announced on August 8, 2022 (the ?Offering? |
|
| August 16, 2022 |
OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2024 Estimated average burden hours per response 1. |
|
| August 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant?s name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of |
|
| August 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of |
|
| August 16, 2022 |
EXHIBIT 99.1 Skylight Health Group Reports Second Quarter 2022 Financial Results and Upsizes Financing Revenue Growth of 134% Year over Year, 108% Growth Compared to the Previous Quarter and Secures entry into Full-Risk Value Based Care in 2022 TORONTO, Aug. 15, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ: SLHG; TSXV: SLHG) (?Skylight Health? or the ?Company?), a multi-state primary |
|
| August 16, 2022 |
Skylight Health Group Inc. Condensed Interim Consolidated Financial Statements June 30, 2022 (Expressed in thousands of Canadian Dollars) (Unaudited) Notice to Reader The accompanying unaudited condensed interim consolidated financial statements of Skylight Health Group Inc. (the "Company") have been prepared by and are the responsibility of management. The unaudited condensed interim consolidated |
|
| August 16, 2022 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Pradyum Sekar, Chief Executive Officer of Skylight Health Group Inc. |
|
| August 16, 2022 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Farooq Akhter, Interim Chief Financial Officer of Skylight Health Group Inc. |
|
| August 16, 2022 |
MANAGEMENT?S DISCUSSION AND ANALYSIS For the three and six months ended June 30, 2022 (Expressed in Canadian Dollars, unless otherwise stated) August 15, 2022 Skylight Health Group Inc. |
|
| August 10, 2022 |
6-K 1 f6k081022.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, |
|
| August 10, 2022 |
Skylight Health Announces Timing of its Second Quarter 2022 Results Conference Call EXHIBIT 99.1 Skylight Health Announces Timing of its Second Quarter 2022 Results Conference Call TORONTO, Aug. 10, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, is pleased to announce that its financial results for the second quarter of 2022 will be released after t |
|
| August 8, 2022 |
Skylight Health Announces Non-Brokered Private Placement of Convertible Debenture Units EXHIBIT 99.1 Skylight Health Announces Non-Brokered Private Placement of Convertible Debenture Units TORONTO, Aug. 08, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, has commenced a non-brokered private placement offering (the ?Offering?) of convertible debenture uni |
|
| August 8, 2022 |
6-K 1 f6k080822.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, |
|
| July 20, 2022 |
Skylight Health Announces Series A Preferred Stock Cash Dividend EXHIBIT 99.1 Skylight Health Announces Series A Preferred Stock Cash Dividend TORONTO, July 20, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ: SLHG: SLHGP; TSXV: SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series |
|
| July 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of pr |
|
| July 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of pr |
|
| July 14, 2022 |
Skylight Health Announces Re-Appointment of Co-Founder Kash Qureshi as President EXHIBIT 99.1 Skylight Health Announces Re-Appointment of Co-Founder Kash Qureshi as President TORONTO, July 14, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today announced the re-appointment of Co-Founder and current Director and Chief Corporate Officer Kash Qures |
|
| June 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of pr |
|
| June 29, 2022 |
Skylight Health Announces Results of 2022 Annual General & Special Meeting of Shareholders EXHIBIT 99.1 Skylight Health Announces Results of 2022 Annual General & Special Meeting of Shareholders TORONTO, June 29, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, is pleased to announce the results of voting at its annual general meeting of the shareholders whi |
|
| June 24, 2022 |
Skylight Health Announces Appointment of Interim Chief Financial Officer and Corporate Update EXHIBIT 99.1 Skylight Health Announces Appointment of Interim Chief Financial Officer and Corporate Update TORONTO, June 16, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today announces the appointment of Farooq Akhter as Interim Chief Financial Officer (CFO), effe |
|
| June 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of pr |
|
| June 23, 2022 |
6-K 1 f6k062322.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, O |
|
| June 23, 2022 |
Skylight Health Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency EXHIBIT 99.1 Skylight Health Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency TORONTO, June 23, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today announced that the Company received written notification (the "Notification Letter") from The Nasda |
|
| June 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of pr |
|
| June 21, 2022 |
Skylight Health Announces Series A Preferred Stock Cash Dividend EXHIBIT 99.1 Skylight Health Announces Series A Preferred Stock Cash Dividend TORONTO, June 20, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ: SLHG: SLHGP; TSXV: SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series |
|
| May 20, 2022 |
Skylight Health Announces Series A Preferred Stock Cash Dividend EXHIBIT 99.1 Skylight Health Announces Series A Preferred Stock Cash Dividend TORONTO, May 20, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ: SLHG: SLHGP; TSXV: SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series A |
|
| May 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of pri |
|
| May 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of pri |
|
| May 17, 2022 |
EXHIBIT 99.1 Skylight Health Group Reports First Quarter 2022 Financial Results Revenue Growth of 255% Year over Year and Entry into Full-Risk in 2022 TORONTO, May 16, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today announced its financial results for the first |
|
| May 16, 2022 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Pradyum Sekar, Chief Executive Officer of Skylight Health Group Inc. |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant?s name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of pri |
|
| May 16, 2022 |
MANAGEMENT?S DISCUSSION AND ANALYSIS For the three months ended March 31, 2022 (Expressed in Canadian Dollars, unless otherwise stated) May 16, 2022 Skylight Health Group Inc. |
|
| May 16, 2022 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Andrew Elinesky, Chief Financial Officer of Skylight Health Group Inc. |
|
| May 16, 2022 |
Skylight Health Group Inc. Condensed Interim Consolidated Financial Statements March 31, 2022 (Expressed in thousands of Canadian Dollars) (Unaudited) SKYLIGHT HEALTH GROUP INC. Condensed Interim Consolidated Statements of Financial Position (Expressed in thousands of Canadian dollars) (Unaudited) March 31, 2022 December 31, 2021 $ $ ASSETS Current assets Cash and cash equivalents 4,204 11,653 Tra |
|
| May 12, 2022 |
Skylight Health Announces Earnings Call and Corporate Update EXHIBIT 99.1 Skylight Health Announces Earnings Call and Corporate Update TORONTO, May 11, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG;TSXV:SLHG (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today announced that its financial results for the first quarter of 2022 will be released after the close of market on May 16th, 20 |
|
| May 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of pri |
|
| May 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of pri |
|
| May 6, 2022 |
EXHIBIT 99.1 Skylight Health Completes Largest Acquisition to date and Enters Medicare Advantage Global Risk Skylight doubles top line revenue and adds over 5,000 patient lives NeighborMD (?NMD?) adds 9 practices across Central and Southern Florida with over 2,400 owned and affiliated global capitated risk lives. Unaudited trailing 12 months (TTM) primary care revenue of US $35 million roughly eve |
|
| May 3, 2022 |
EXHIBIT 99.1 Skylight Health Executes Definitive Agreement to Acquire NeighborMD to Expand in Florida and Enters Medicare Advantage Global Risk Skylight executes a definitive agreement for the largest acquisition to date and arranges a US $20 million credit line facility to fund the acquisition and future deals NeighborMD (?NMD?) will add 9 practices across Central and Southern Florida with over 2 |
|
| May 3, 2022 |
NT 20-F 1 d355886dnt20f.htm NT 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Repor |
|
| May 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of pri |
|
| April 29, 2022 |
EXHIBIT 99.1 Skylight Health Provides Clinical Research Update Skylight Health Research has been selected to participate in 10 clinical research studies since its launch TORONTO, April 29, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG;TSXV:SLHG (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today provides an update on the s |
|
| April 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of p |
|
| April 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of p |
|
| April 19, 2022 |
Skylight Health Announces Series A Preferred Stock Cash Dividend EXHIBIT 99.1 Skylight Health Announces Series A Preferred Stock Cash Dividend TORONTO, April 18, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ: SLHG: SLHGP; TSXV: SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series |
|
| April 5, 2022 |
EXHIBIT 99.1 Skylight Health and Collaborative Health Systems Announce Joint Venture to Partner on Value-Based Care TORONTO and TAMPA, Fla., April 05, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG; TSXV: SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today announced a joint venture (?JV?) partnership with Collaborativ |
|
| April 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of p |
|
| March 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant?s name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of p |
|
| March 30, 2022 |
Form 52-109F1 Certification of Annual Filings Full Certificate EX-99.5 6 cfocertq42021.htm EX-99.5 Form 52-109F1 Certification of Annual Filings Full Certificate I, Andrew Elinesky, Chief Financial Officer of Skylight Health Group Inc., certify the following: 1.Review: I have reviewed the AIF, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference in the AIF (together, th |
|
| March 30, 2022 |
FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS FULL CERTIFICATE FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS FULL CERTIFICATE This certificate is being filed on the same date that Skylight Health Group Inc. |
|
| March 30, 2022 |
FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS FULL CERTIFICATE EX-99.3 4 ceocertq32021-refiled.htm EX-99.3 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS FULL CERTIFICATE This certificate is being filed on the same date that Skylight Health Group Inc. has refiled its condensed interim consolidated financial statements and interim MD&A as at September 30, 2021 and for the three and nine months ended September 30, 2021 and 2020, together with the notes |
|
| March 30, 2022 |
FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE EX-99.3 4 ceocertq12021-refiled.htm EX-99.3 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE This certificate is being filed on the same date that Skylight Health Group Inc. has refiled its condensed interim consolidated financial statements and interim MD&A as at March 31, 2021 and for the three months ended March 31, 2021 and 2020, together with the notes |
|
| March 30, 2022 |
Form 52-109F1 Certification of Annual Filings Full Certificate EX-99.4 5 ceocertq42021.htm EX-99.4 Form 52-109F1 Certification of Annual Filings Full Certificate I, Pradyum Sekar, Chief Executive Officer of Skylight Health Group Inc., certify the following: 1.Review: I have reviewed the AIF, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference in the AIF (together, the |
|
| March 30, 2022 |
6-K 1 form6-kq32021xrefiled.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant’s name into English) 5520 Explorer Drive, Suite 402 Missis |
|
| March 30, 2022 |
EX-99.2 3 skylighthealthgroupincmdaq.htm EX-99.2 MANAGEMENT’S DISCUSSION AND ANALYSIS (Restated) For the three and nine months ended September 30, 2021 (Expressed in Canadian Dollars, unless otherwise stated) March 30, 2022 Skylight Health Group Inc. (formerly CB2 Insights Inc.) Management Discussion and Analysis For the three and nine months ended September 30, 2021 Introduction The following man |
|
| March 30, 2022 |
6-K 1 form6-kq12021xrefiled.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant’s name into English) 5520 Explorer Drive, Suite 402 Missis |
|
| March 30, 2022 |
FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS FULL CERTIFICATE FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS FULL CERTIFICATE This certificate is being filed on the same date that Skylight Health Group Inc. |
|
| March 30, 2022 |
Skylight Health Group Inc. Audited Consolidated Financial Statements For the years ended December 31, 2021 and 2020 SKYLIGHT HEALTH GROUP INC. CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2021 AND 2020 Independent Auditor's Report 1 Consolidated Financial Statements Consolidated Statements of Financial Position 5 Consolidated Statements of Loss and Comprehensive Loss 6 Consolidated Statements of |
|
| March 30, 2022 |
Annual Information Form SKYLIGHT HEALTH GROUP INC. For the year ended December 31, 2021 Dated as of March 30, 2022 TABLE OF CONTENTS PRELIMINARY NOTES 1 FORWARD-LOOKING INFORMATION 1 NON-IFRS MEASURES 2 CORPORATE STRUCTURE 2 GENERAL DEVELOPMENT OF THE BUSINESS 4 DESCRIPTION OF THE BUSINESS 10 RISK FACTORS 13 DIVIDENDS 22 DESCRIPTION OF CAPITAL STRUCTURE 23 MARKET FOR SECURITIES 23 ESCROWED SECURIT |
|
| March 30, 2022 |
Skylight Health Group Inc. (formerly CB2 Insights Inc.) Condensed Interim Consolidated Financial Statements (Restated) September 30, 2021 (Expressed in thousands of Canadian Dollars) (Unaudited) Notice to Reader The unaudited condensed interim consolidated financial statements have been re-filed to correct identified errors related to the accounting treatment of certain revenue transactions. See n |
|
| March 30, 2022 |
FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE EX-99.4 5 cfocertq12021-refiled.htm EX-99.4 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE This certificate is being filed on the same date that Skylight Health Group Inc. has refiled its condensed interim consolidated financial statements and interim MD&A as at March 31, 2021 and for the three months ended March 31, 2021 and 2020, together with the notes |
|
| March 30, 2022 |
FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS FULL CERTIFICATE EX-99.4 5 cfocertq32021-refiled.htm EX-99.4 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS FULL CERTIFICATE This certificate is being filed on the same date that Skylight Health Group Inc. has refiled its condensed interim consolidated financial statements and interim MD&A as at September 30, 2021 and for the three and nine months ended September 30, 2021 and 2020, together with the notes |
|
| March 30, 2022 |
MANAGEMENT?S DISCUSSION AND ANALYSIS (Restated) For the three and six months ended June 30, 2021 (Expressed in Canadian Dollars, unless otherwise stated) March 30, 2022 Skylight Health Group Inc (formerly CB2 Insights Inc) Management Discussion and Analysis For the three and six months ended June 30, 2021 Introduction The following management?s discussion and analysis (?MD&A?) of the financial condition and results of the operations of Skylight Health Group Inc. |
|
| March 30, 2022 |
Skylight Health Group Inc. (formerly CB2 Insights Inc.) Condensed Interim Consolidated Financial Statements (Restated) March 31, 2021 (Expressed in Canadian Dollars) (Unaudited) Notice to Reader The accompanying unaudited condensed interim consolidated financial statements of Skylight Health Group Inc. (the "Company") have been prepared by and are the responsibility of management. The unaudited co |
|
| March 30, 2022 |
MANAGEMENT?S DISCUSSION AND ANALYSIS (Restated) For the three months ended March 31, 2021 (Expressed in Canadian Dollars, unless otherwise stated) March 30, 2022 Skylight Health Group Inc (formerly CB2 Insights Inc) Management Discussion and Analysis For the three months ended March 31, 2021 Introduction The following restated management?s discussion and analysis (?MD&A?) of the financial condition and results of the operations of Skylight Health Group Inc. |
|
| March 30, 2022 |
Skylight Health Group Inc. (formerly CB2 Insights Inc.) Condensed Interim Consolidated Financial Statements (Restated) June 30, 2021 (Expressed in thousands of Canadian Dollars) (Unaudited) Notice to Reader The unaudited condensed interim consolidated financial statements have been re-filed to correct identified errors related to the accounting treatment of certain revenue transactions. See note 1 |
|
| March 30, 2022 |
EXHIBIT 99.1 Skylight Health Group Reports Fourth Quarter and Full-Year 2021 Financial Results Revenue Growth of 3,842% Year over Year and 8% Growth Compared to the Previous Quarter TORONTO, March 30, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today announced its |
|
| March 30, 2022 |
6-K 1 form6-kq22021xrefiled.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant’s name into English) 5520 Explorer Drive, Suite 402 Missis |
|
| March 30, 2022 |
MANAGEMENT?S DISCUSSION AND ANALYSIS For the Years Ended December 31, 2021 and 2020 (Expressed in Canadian Dollars, unless otherwise stated) March 30, 2022 Skylight Health Group Inc (formerly CB2 Insights Inc) Management Discussion and Analysis For the years ended December 31, 2021 and 2020 Introduction The following management?s discussion and analysis (?MD&A?) of the financial condition and results of the operations of Skylight Health Group Inc. |
|
| March 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of p |
|
| March 24, 2022 |
Skylight Health Announces Q4 2021 Earnings Call EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Skylight Health Announces Q4 2021 Earnings Call TORONTO, March 24, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc (NASDAQ:SLHG; TSXV: SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, today announced that its financial results for the fourth quarter of 2021 will be released after the clos |
|
| March 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of p |
|
| March 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of p |
|
| March 18, 2022 |
Skylight Health Announces Series A Preferred Stock Cash Dividend EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Skylight Health Announces Series A Preferred Stock Cash Dividend TORONTO, March 18, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ: SLHG: SLHGP; TSXV: SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, announced that its Board of Directors has authorized, and the Company has decla |
|
| February 17, 2022 |
Skylight Health Announces Series A Preferred Stock Cash Dividend EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Skylight Health Announces Series A Preferred Stock Cash Dividend TORONTO, Feb. 16, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ: SLHG: SLHGP; TSXV: SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, announced that its Board of Directors has authorized, and the Company has declar |
|
| February 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address o |
|
| January 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2022 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of |
|
| January 20, 2022 |
Skylight Health Announces Series A Preferred Stock Cash Dividend EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Skylight Health Announces Series A Preferred Stock Cash Dividend TORONTO, Jan. 20, 2022 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ: SLHG: SLHGP; TSXV: SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, announced that its Board of Directors has authorized, and the Company has declar |
|
| December 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Exact name of Registrant as specified in its charter) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Ad |
|
| December 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address o |
|
| December 22, 2021 |
Skylight Health Announces Series A Preferred Stock Cash Dividend EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Skylight Health Announces Series A Preferred Stock Cash Dividend TORONTO, Dec. 22, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ: SLHG: SLHGP; TSXV: SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, announced that its Board of Directors has authorized, and the Company has declar |
|
| December 15, 2021 |
EXHIBIT 99.1 Skylight Health Group Completes Divestiture of Legacy Business to New Frontier Data Skylight Health Group cements focus and future on shifting fee-for-service primary care practices into value-based care TORONTO, Dec. 15, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ: SLHG; TSXV:SLHG) (?Skylight Health?, ?Skylight? or the ?Company?), a multi-state primary care group in th |
|
| December 15, 2021 |
FORM 51-102F3 MATERIAL CHANGE REPORT UNDER NATIONAL INSTRUMENT 51-102 Exhibit 99.1 FORM 51-102F3 MATERIAL CHANGE REPORT UNDER NATIONAL INSTRUMENT 51-102 1. Name and Address of Company Skylight Health Group Inc. (the “Company”) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 2. Date of Material Change December 15, 2021 3. News Release A news release with respect to the material change referred to in this report was disseminated through Globe News Wire on |
|
| December 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Exact name of Registrant as specified in its charter) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Ad |
|
| December 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address o |
|
| December 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Exact name of Registrant as specified in its charter) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Ad |
|
| December 7, 2021 |
EX-99.5 6 d212995dex995.htm EX-99.5 Exhibit 99.5 Grant Thornton LLP December 1, 2021 Suite 501 201 City Centre Drive Mississauga, ON To: Alberta Securities Commission British Columbia Securities Commission Manitoba Securities Commission Ontario Securities Commission L5B 2T4 T +1 416 366 0100 F +1 905 804 0509 www.GrantThornton.ca Dear Sirs/Mesdames: Re: Skylight Health Group Inc. (formerly CB2 Tec |
|
| December 7, 2021 |
EX-99.2 3 d212995dex992.htm EX-99.2 Exhibit 99.2 UNDERWRITING AGREEMENT $5,775,000 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares SKYLIGHT HEALTH GROUP INC. (incorporated under the Canada Business Corporations Act ) December 1, 2021 The Benchmark Company, LLC As Representative of the Underwriters named on Schedule I hereto The Benchmark Company, LLC 150 East 58th Street, 17th Floo |
|
| December 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address o |
|
| December 7, 2021 |
EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Skylight Health Announces Closing of Public Offering of 275,000 Shares of Series A Cumulative Redeemable Perpetual Preferred Stock TORONTO, Dec. 07, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG; TSXV: SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, today announced the cl |
|
| December 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Exact name of Registrant as specified in its charter) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Ad |
|
| December 7, 2021 |
FORM 51-102F3 MATERIAL CHANGE REPORT UNDER NATIONAL INSTRUMENT 51-102 EX-99.1 2 d212995dex991.htm EX-99.1 Exhibit 99.1 FORM 51-102F3 MATERIAL CHANGE REPORT UNDER NATIONAL INSTRUMENT 51-102 1. Name and Address of Company Skylight Health Group Inc. (the “Company”) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 2. Date of Material Change December 6, 2021 3. News Release A news release with respect to the material change referred to in this report was disse |
|
| December 7, 2021 |
Exhibit 99.4 Kathleen E. Skerrett Direct Line: 416.865.6660 Direct Fax: 416.865.6636 [email protected] December 1, 2021 FILED VIA SEDAR Ontario Securities Commission Alberta Securities Commission British Columbia Securities Commission The Manitoba Securities Commission Dear Sirs/Mesdames, Re: Skylight Health Group Inc. (the ?Issuer?) Issuer Profile No.: 45044 - Prospectus Supplement dated Decemb |
|
| December 7, 2021 |
1345 AVENUE OF THE AMERICAS, 11 Exhibit 99.3 1345 AVENUE OF THE AMERICAS, 11th FLOOR NEW YORK, NEW YORK 10105 TELEPHONE: (212) 370-1300 FACSIMILE: (212) 370-7889 www.egsllp.com December 1, 2021 FILED VIA SEDAR Ontario Securities Commission Alberta Securities Commission British Columbia Securities Commission The Manitoba Securities Commission Dear Sirs/Mesdames, Re: Skylight Health Group Inc. (the “Issuer”) Issuer Profile No.: 45 |
|
| December 2, 2021 |
Filed Pursuant to General Instruction II.L of Form F-10; File No. 333-260070 No securities regulatory authority has expressed an opinion about these securities and it is an offence to claim otherwise. This prospectus supplement, together with the accompanying amended and restated short form base shelf prospectus dated October 4, 2021 to which it relates, as amended or supplemented, and each docume |
|
| December 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address o |
|
| December 2, 2021 |
EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Skylight Health Announces Pricing of Public Offering of 275,000 Shares of Series A Cumulative Redeemable Perpetual Preferred Stock TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc (NASDAQ:SLHG; TSXV: SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, today announced the pri |
|
| December 1, 2021 |
Certificate of Amendment, dated April 1, 2021 Exhibit 3.5 Certificate of Amendment Certificat de modification Canada Business Corporations Act Loi canadienne sur les sociétés par actions Skylight Health Group Inc. Corporate name / Dénomination sociale 1055740-4 Corporation number / Numéro de société I HEREBY CERTIFY that the articles of the above-named corporation are amended under section 178 of the Canada Business Corporations Act as set ou |
|
| December 1, 2021 |
Certificate of Amendment, dated December 20, 2018 Exhibit 3.3 Certificate of Amendment Certificat de modification Canada Business Corporations Act Loi canadienne sur les soci?t?s par actions CB2 Insights Inc. Corporate name / D?nomination sociale 1055740-4 Corporation number / Num?ro de soci?t? I HEREBY CERTIFY that the articles of the above-named corporation are amended under section 178 of the Canada Business Corporations Act as set out in the |
|
| December 1, 2021 |
Certificate of Amendment, dated November 23, 2020 Exhibit 3.4 Certificate of Amendment Certificat de modification Canada Business Corporations Act Loi canadienne sur les soci?t?s par actions Skylight Health Group Inc. Corporate name / D?nomination sociale 1055740-4 Corporation number / Num?ro de soci?t? I HEREBY CERTIFY that the articles of the above-named corporation are amended under section 178 of the Canada Business Corporations Act as set ou |
|
| December 1, 2021 |
Certificate of Incorporation, dated December 27, 2017 Exhibit 3.1 Certificate of Incorporation Certificat de constitution Canada Business Corporations Act Loi canadienne sur les sociétés par actions 10557404 Canada Corp. Corporate name / Dénomination sociale 1055740-4 Corporation number / Numéro de société I HEREBY CERTIFY that the above-named corporation, the articles of incorporation of which are attached, is incorporated under the Canada Business |
|
| December 1, 2021 |
Certificate of Amendment, dated May 12, 2021 EX-3.6 7 d227417dex36.htm EX-3.6 Exhibit 3.6 Certificate of Amendment Certificat de modification Canada Business Corporations Act Loi canadienne sur les sociétés par actions Skylight Health Group Inc. Corporate name / Dénomination sociale 1055740-4 Corporation number / Numéro de société I HEREBY CERTIFY that the articles of the above-named corporation are amended under section 178 of the Canada Bu |
|
| December 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Skylight Health Group Inc. (Exact name of registrant as specified in its charter) Canada Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identificat |
|
| December 1, 2021 |
Certificate of Amendment, dated December 1, 2021 Exhibit 3.7 Certificate of Amendment Certificat de modification Canada Business Corporations Act Loi canadienne sur les soci?t?s par actions Skylight Health Group Inc. Corporate name / D?nomination sociale 1055740-4 Corporation number / Num?ro de soci?t? I HEREBY CERTIFY that the articles of the above-named corporation are amended under section 27 of the Canada Business Corporations Act as set out |
|
| December 1, 2021 |
Certificate of Amendment, as amended, dated March 19, 2018 Exhibit 3.2 Certificate of Amendment Canada Business Corporations Act Certificat de modification Loi canadienne sur les sociétés par actions 10557404 Canada Corp. Corporate name / Dénomination sociale 1055740-4 Corporation number / Numéro de société I HEREBY CERTIFY that the articles of the above-named corporation are amended under sections 27 and 178 of the Canada Business Corporations Act as set |
|
| November 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address o |
|
| November 29, 2021 |
EXHIBIT 99.1 Skylight Health Group to Present at The Benchmark Company?s Discovery One on One Virtual Video Investor Conference TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care group in the United States, will be presenting at the Benchmark Company?s Discovery One on One Virtual Video Inve |
|
| November 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address o |
|
| November 16, 2021 |
EXHIBIT 99.1 Skylight Health Group Reports Record Third Quarter 2021 Financial Results Revenue Growth of 269% Year over Year and 16% Growth Compared to the Previous Quarter TORONTO, Nov. 15, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today announced its financial |
|
| November 15, 2021 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Pradyum Sekar, Chief Executive Officer of Skylight Health Group Inc. |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant?s name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address o |
|
| November 15, 2021 |
MANAGEMENT?S DISCUSSION AND ANALYSIS For the three and nine months ended September 30, 2021 (Expressed in Canadian Dollars, unless otherwise stated) November 15, 2021 Skylight Health Group Inc. |
|
| November 15, 2021 |
Skylight Health Group Inc. (formerly CB2 Insights Inc.) Condensed Interim Consolidated Financial Statements September 30, 2021 (Expressed in thousands of Canadian Dollars) (Unaudited) SKYLIGHT HEALTH GROUP INC. (formerly CB2 Insights Inc.) Condensed Interim Consolidated Statements of Financial Position (Expressed in thousands of Canadian Dollars) (Unaudited) September 30, 2021 December 31, 2020 $ |
|
| November 15, 2021 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Andrew Elinesky, Chief Financial Officer of Skylight Health Group Inc. |
|
| November 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address o |
|
| November 12, 2021 |
Skylight Health Announces Offering of Series A Cumulative Redeemable Perpetual Preferred Stock Filed Pursuant to Rule 433 of the Securities Act of 1933 Issuer Free Writing Prospectus dated November 10, 2021 Registration No. |
|
| November 12, 2021 |
Skylight Health Announces Offering of Series A Cumulative Redeemable Perpetual Preferred Stock EXHIBIT 99.1 Skylight Health Announces Offering of Series A Cumulative Redeemable Perpetual Preferred Stock TORONTO, Nov. 11, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc (NASDAQ:SLHG; TSXV: SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today announced the launch of a proposed underwritten public offering (the ?Offering?) of its |
|
| November 10, 2021 |
Filed Pursuant to Rule 433 of the Securities Act of 1933 Issuer Free Writing Prospectus dated November 10, 2021 Registration No. |
|
| November 10, 2021 |
SUPPL 1 d211332dsuppl.htm SUPPL Filed Pursuant to General Instruction II.L of Form F-10; File No. 333-260070 A copy of this preliminary prospectus supplement has been filed with the securities regulatory authorities in Alberta, British Columbia, Manitoba and Ontario, but has not yet become final for the purpose of the sale of securities. Information contained in this preliminary prospectus supplem |
|
| November 9, 2021 |
Skylight Health Announces Q3 2021 Earnings Conference Call EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Skylight Health Announces Q3 2021 Earnings Conference Call TORONTO, Nov. 09, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc (NASDAQ:SLHG; TSXV: SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, today announced that its financial results for the third quarter of 2021 will be released after |
|
| November 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address o |
|
| October 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of |
|
| October 29, 2021 |
EXHIBIT 99.1 Skylight Health Group Executes Definitive Asset Purchase Agreement to Divest Legacy Business to New Frontier Data TORONTO, Oct. 29, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ: SLHG; TSXV:SLHG) (?Skylight Health?, ?Skylight? or the ?Company?), a multi-state primary care group in the United States, today announced the execution of a Definitive Agreement with New Frontier |
|
| October 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of |
|
| October 12, 2021 |
EXHIBIT 99.1 Skylight Health Bolsters Value-Based Care Capability as Industry Veteran Greg Sieman Joins Leadership Team TORONTO, Oct. 12, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc (NASDAQ:SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, is pleased to announce Greg Sieman as senior vice president (SVP) of marketing and |
|
| October 7, 2021 |
EXHIBIT 99.1 Skylight Health Partners with Major National Direct Contracting Entity for Value-Based Care Participation TORONTO, Oct. 07, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ: SLHG; TSXV:SLHG) (“Skylight Health”, “Skylight” or the “Company”), a multi-state primary care group in the United States, today announced the execution of a Participation Provider Contract with a leading |
|
| October 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of |
|
| October 5, 2021 |
October 5, 2021 VIA EDGAR Securities and Exchange Commission 100 F. Street, NE Washington, DC 20549 Re: Skylight Health Group Inc. Request for Withdrawal Pursuant to Rule 477 of Registration Statement on Form F-10 (File No. 333-255444) Ladies and Gentleman: On behalf of Skylight Health Group Inc. (?we,? ?us,? ?our,? or the ?Company?), we hereby submit this letter to notify the Securities and Excha |
|
| October 5, 2021 |
As filed with the Securities and Exchange Commission on October 5, 2021 As filed with the Securities and Exchange Commission on October 5, 2021 Registration No. |
|
| October 5, 2021 |
Exhibit 4.10 FORM 51-102F3 MATERIAL CHANGE REPORT UNDER NATIONAL INSTRUMENT 51-102 1. Name and Address of Company Skylight Health Group Inc. (the “Company”) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 2. Date of Material Change May 18, 2021 3. News Release A news release with respect to the material change referred to in this report was disseminated through Globe News Wire on May 1 |
|
| September 15, 2021 |
Skylight Health Group Enters New State Acquiring Pennsylvania Clinic Group Aspire Health Concepts EXHIBIT 99.1 Skylight Health Group Enters New State Acquiring Pennsylvania Clinic Group Aspire Health Concepts Skylight is acquiring a controlling interest in Pennsylvania-based Aspire Health Concepts, Inc., operating a network of 2 clinics servicing over 10,000 patients annually including over 2,000 Medicare and Medicare Advantage lives. Company expects to enroll the eligible Medicare lives in it |
|
| September 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address |
|
| September 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address |
|
| September 13, 2021 |
EXHIBIT 99.1 Skylight Health to Participate in the Lake Street Capital Markets 5th Annual Best Ideas Growth (BIG5) Conference TORONTO, Sept. 13, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ: SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today announced that the Company will participate in the Lake Street Capit |
|
| August 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of |
|
| August 26, 2021 |
Skylight Health Appoints Mohammad Bataineh as President EXHIBIT 99.1 Skylight Health Appoints Mohammad Bataineh as President TORONTO, Aug. 26, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today announced the appointment of Mohammad Bataineh as the Company?s new President. Brings over 25 years of experience working in pr |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Exact name of Registrant as specified in its charter) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Addr |
|
| August 16, 2021 |
EX-99.1 2 d136171dex991.htm EX-99.1 Exhibit 99.1 Skylight Health Group Inc. (formerly CB2 Insights Inc.) Condensed Interim Consolidated Financial Statements June 30, 2021 (Expressed in thousands of Canadian Dollars) (Unaudited) SKYLIGHT HEALTH GROUP INC. (formerly CB2 Insights Inc.) Condensed Interim Consolidated Statements of Financial Position (Expressed in thousands of Canadian Dollars) (Unaudi |
|
| August 16, 2021 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE EX-99.4 5 d136171dex994.htm EX-99.4 Exhibit 99.4 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Andrew Elinesky, Chief Financial Officer of Skylight Health Group Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the “interim filings”) of Skylight Health Group Inc. (the “issuer”) for the interim period ended June |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of |
|
| August 16, 2021 |
EXHIBIT 99.1 Skylight Health Group Reports Record Second Quarter 2021 Financial Results Revenue Growth of 184% Year over Year and 103% Growth Compared to the Previous Quarter TORONTO, Aug. 16, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today announced its financi |
|
| August 16, 2021 |
Exhibit 99.2 MANAGEMENT’S DISCUSSION AND ANALYSIS For the three and six months ended June 30, 2021 (Expressed in Canadian Dollars, unless otherwise stated) August 16, 2021 Skylight Health Group Inc. (formerly CB2 Insights Inc.) Management Discussion and Analysis For the three and six months ended June 30, 2021 Introduction The following management’s discussion and analysis (“MD&A”) of the financia |
|
| August 16, 2021 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE EX-99.3 4 d136171dex993.htm EX-99.3 Exhibit 99.3 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Pradyum Sekar, Chief Executive Officer of Skylight Health Group Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the “interim filings”) of Skylight Health Group Inc. (the “issuer”) for the interim period ended June 3 |
|
| August 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of |
|
| August 10, 2021 |
Skylight Health Announces Q2 2021 Earnings Conference Call EXHIBIT 99.1 Skylight Health Announces Q2 2021 Earnings Conference Call TORONTO, Aug. 10, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc (NASDAQ:SLHG; TSXV: SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today announced that its financial results for the second quarter of 2021 will be released after the close of market on August 16, |
|
| August 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of |
|
| August 5, 2021 |
Skylight Health Announces Expansion of ClinEdge Partnership and Award for First Colorado Study EXHIBIT 99.1 Skylight Health Announces Expansion of ClinEdge Partnership and Award for First Colorado Study Skylight Health expands its Colorado primary care network to act as a clinical research site partner for ClinEdge; The expanded partnership with ClinEdge will bring industry-sponsored trials to Skylight Health?s clinics in Colorado; Skylight announces the award of its first clinical trial in |
|
| July 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of pr |
|
| July 14, 2021 |
EXHIBIT 99.1 Skylight Health Acquires ACO Partners and Enters Value-Based Contracting for Traditional Medicare Patients TORONTO, July 14, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ: SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care group in the United States, today announced the acquisition of ACO Partners LLC (?AP?), a new Accountable Care Organizat |
|
| July 7, 2021 |
Skylight Health Announces Appointment of Dr. Kit Brekhus as Chief Medical Officer EXHIBIT 99.1 Skylight Health Announces Appointment of Dr. Kit Brekhus as Chief Medical Officer TORONTO, July 07, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ: SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today announced the appointment of Dr. Kit Brekhus, MD, as Chief Medical Officer (CMO). Dr. Brekhus will b |
|
| July 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of pr |
|
| June 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of pr |
|
| June 29, 2021 |
Skylight Health Announces Results of 2021 Annual General & Special Meeting of Shareholders EXHIBIT 99.1 Skylight Health Announces Results of 2021 Annual General & Special Meeting of Shareholders TORONTO, June 29, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc (NASDAQ:SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-specialty healthcare systems in the United States, is pleased to announce the results of voting at its annual general meeting of the shareholders which was h |
|
| June 24, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of pr |
|
| June 24, 2021 |
Skylight Health Announces Acquisition of Florida Primary Care Group Doctors Center Inc. EXHIBIT 99.1 Skylight Health Announces Acquisition of Florida Primary Care Group Doctors Center Inc. TORONTO, June 24, 2021 (GLOBE NEWSWIRE) - Skylight Health Group Inc. (NASDAQ: SLHG; TSXV:SLHG) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, is pleased to announce that the Company has acquired the Doctors Center Inc., a primary care group w |
|
| June 2, 2021 |
Exhibit 99.1 NEWS RELEASE Skylight Health Group Reports Record First Quarter 2021 Financial Results Revenue Grew 76% Year over Year and 62% Sequentially TORONTO, ON ? May 31, 2021 ? Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today announced its financial results for the first quarter en |
|
| June 2, 2021 |
FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS Exhibit 99.6 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS This certificate is being filed on the same date that Skylight Health Group Inc. (the “issuer”) has refiled interim financial statements for the interim period ended March 31, 2021. I, Andrew Elinesky, Chief Financial Officer of Skylight Health Group Inc., certify the following: 1. Review: I have reviewed the interim financial re |
|
| June 2, 2021 |
FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE Exhibit 99.4 FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Andrew Elinesky, Chief Financial Officer of Skylight Health Group Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Skylight Health Group Inc. (the “issuer”) for the interim period ended March 31, 2021. 2. No misre |
|
| June 2, 2021 |
EXHIBIT 99.1 Skylight Health Announces Award of US Clinical Trial Skylight Health has been selected as a clinical site to enroll patients for a clinical research trial investigating ADG20, a broadly neutralizing monoclonal antibody, for use in the prevention of COVID-19 The Skylight Health Research Team will work to bring industry-sponsored clinical trials to Skylight Health clinics, beginning in |
|
| June 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Translation of registrant's name into English) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address of pr |
|
| June 2, 2021 |
FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE Exhibit 99.3 FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Prad Sekar, Chief Executive Officer of Skylight Health Group Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the ?interim filings?) of Skylight Health Group Inc. (the ?issuer?) for the interim period ended March 31, 2021. 2. No misreprese |
|
| June 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Exact name of Registrant as specified in its charter) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Addres |
|
| June 2, 2021 |
Exhibit 99.2 MANAGEMENT?S DISCUSSION AND ANALYSIS For the three months ended March 31, 2021 (Expressed in Canadian Dollars, unless otherwise stated) May 31, 2021 Skylight Health Group Inc. (formerly CB2 Insights Inc.) Management Discussion and Analysis For the three months ended March 31, 2021 Introduction The following management?s discussion and analysis (?MD&A?) of the financial condition and r |
|
| June 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Exact name of Registrant as specified in its charter) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Addres |
|
| June 2, 2021 |
FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS EX-99.5 6 d172175dex995.htm EX-99.5 Exhibit 99.5 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS This certificate is being filed on the same date that Skylight Health Group Inc. (the “issuer”) has refiled interim financial statements for the interim period ended March 31, 2021. I, Prad Sekar, Chief Executive Officer of Skylight Health Group Inc., certify the following: 1. Review: I have re |
|
| June 2, 2021 |
Exhibit 99.1 Skylight Health Group Inc. (formerly CB2 Insights Inc.) Condensed Interim Consolidated Financial Statements March 31, 2021 (Expressed in Canadian Dollars) (Unaudited) Notice to Reader The accompanying unaudited condensed interim consolidated financial statements of Skylight Health Group Inc. (the ?Company?) have been prepared by and are the responsibility of management. The unaudited |
|
| June 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Exact name of Registrant as specified in its charter) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Addres |
|
| June 1, 2021 |
NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS SKYLIGHT HEALTH GROUP INC. Exhibit 99.1 NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS SKYLIGHT HEALTH GROUP INC. NOTICE IS HEREBY GIVEN THAT the annual general and special meeting (the ?Meeting?) of the holders (the ?Shareholders?) of common shares (?Shares?) of Skylight Health Group Inc. (?Skylight? or the ?Corporation?) will be held virtually through the platform of AGM Connect to facilitate an interactive |
|
| June 1, 2021 |
Exhibit 99.2 ANNUAL GENERAL & SPECIAL MEETING OF SHAREHOLDERS TUESDAY 29 9:00AM JUNE 2021 (EDT) All information related to the meeting can be found at www.agmconnect.com/Skylight2021 You can attend the meeting virtually using the login credentials below at: https://app.agmconnect.com You can vote and access the meeting via: computer Smartphone or calling: Tablet +1.855.839.3715 - DETACH HERE — DET |
|
| June 1, 2021 |
Exhibit 99.3 SKYLIGHT HEALTH GROUP INC. 5520 Explorer Drive, Suite 402 Mississauga, Ontario, L4W 5L1 MANAGEMENT INFORMATION CIRCULAR FOR THE ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 29, 2021 This management information circular (this ?Circular?) is being furnished in connection with the solicitation, by management of Skylight Health Group Inc. (the ?Corporation?), of p |
|
| May 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Exact name of Registrant as specified in its charter) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address |
|
| May 27, 2021 |
Skylight Health Group Announces Expected Date of NASDAQ Exchange Listing Exhibit 99.1 NEWS RELEASE Skylight Health Group Announces Expected Date of NASDAQ Exchange Listing TORONTO, ON ? May 27, 2021 ? Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, is pleased to announce that further to its press release dated May 13, 2021, it has received confirmation from The N |
|
| May 26, 2021 |
FORM 51-102F3 MATERIAL CHANGE REPORT UNDER NATIONAL INSTRUMENT 51-102 Exhibit 99.2 FORM 51-102F3 MATERIAL CHANGE REPORT UNDER NATIONAL INSTRUMENT 51-102 1. Name and Address of Company Skylight Health Group Inc. (the ?Company?) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 2. Date of Material Change May 26, 2021 3. News Release A news release with respect to the material change referred to in this report was disseminated through Globe News Wire on May 2 |
|
| May 26, 2021 |
Skylight Health Announces Q1 2021 Earnings Conference Call Exhibit 99.1 Skylight Health Announces Q1 2021 Earnings Conference Call TORONTO, May 25, 2021 (GLOBE NEWSWIRE) ? Skylight Health Group Inc (TSXV:SHG; OTCQX: SHGFF) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States today announced that its financial results for the first quarter of 2021 will be released on May 31, 2021. The Company will host a co |
|
| May 26, 2021 |
Exhibit 99.3 NEWS RELEASE Skylight Health Group Announces Closing of $13.8 Million Bought Deal Financing and Share Consolidation NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, ON ? May 26, 2021 ? Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United |
|
| May 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Exact name of Registrant as specified in its charter) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address |
|
| May 20, 2021 |
Exhibit 99.1 NEWS RELEASE Skylight Health Announces $12 Million Bought Deal Public Offering of Common Shares THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES NOR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, May 18, 2021 (GLOBE NEWSWIRE) ? Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (?Skylight Health? o |
|
| May 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Exact name of Registrant as specified in its charter) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address |
|
| May 14, 2021 |
Exhibit 99.2 May 4, 2021 Grant Thornton LLP Suite 501 201 City Centre Drive Mississauga, ON L5B 2T4 To: Alberta Securities Commission T +1 416 366 0100 British Columbia Securities Commission F +1 905 804 0509 Ontario Securities Commission www.GrantThornton.ca Manitoba Securities Commission Re: Notice of Change of Auditor – Skylight Health Group Inc. (formerly CB2 Insights Inc.) We have reviewed t |
|
| May 14, 2021 |
Skylight Health Obtains Conditional Approval to List on NASDAQ Under the Symbol “SLHG” Exhibit 99.4 NEWS RELEASE Skylight Health Obtains Conditional Approval to List on NASDAQ Under the Symbol ?SLHG? TORONTO, ON ? May 13, 2021 ? Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (?Skylight Health? or the ?Company?), a multi-state primary care management group in the United States, today announced that the Company has received conditional approval from The Nasdaq Stock Market LLC ( |
|
| May 14, 2021 |
Exhibit 99.3 May 5, 2021 To: Ontario Securities Commission British Columbia Securities Commission Alberta Securities Commission Manitoba Securities Commission We have read the statements made by Skylight Health Group Inc. in the change of auditor notice dated May 4, 2021, which we understand will be filed pursuant to Section 4.11 of National Instrument 51-102. We agree with the statements concerni |
|
| May 14, 2021 |
Exhibit 99.1 Notice of Change of Auditors Pursuant to National Instrument 51-102 TO: Ontario Securities Commission British Columbia Securities Commission Alberta Securities Commission Manitoba Securities Commission AND TO: PricewaterhouseCoopers LLP Grant Thornton LLP May 4, 2021 Dear Sirs/Mesdames: RE: Notice Regarding Change of Auditor Pursuant to National Instrument 51-102 Notice is hereby give |
|
| May 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Skylight Health Group Inc. (Exact name of registrant as specified in its charter) Canada Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identificat |
|
| May 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2021 Commission File Number: 001-40414 Skylight Health Group Inc. (Exact name of Registrant as specified in its charter) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 (Address |
|
| May 6, 2021 |
Exhibit 4.8 FORM 51-102F3 MATERIAL CHANGE REPORT UNDER NATIONAL INSTRUMENT 51-102 1. Name and Address of Company Skylight Health Group Inc. (the ?Company?) 5045 Orbitor Drive, Building 11, Unit 300 Mississauga, Ontario, L4W 4Y4 2. Date of Material Change January 14, 2021 3. News Release A news release with respect to the material change referred to in this report was disseminated through Globe New |
|
| May 6, 2021 |
Exhibit 4.4 CB2 INSIGHTS INC. 5045 Orbitor Drive, Building 11, Unit 300 Mississauga, Ontario, L4W 4Y4 MANAGEMENT INFORMATION CIRCULAR FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON SEPTEMBER 9, 2020 This management information circular (this ?Circular?) is being furnished in connection with the solicitation, by management of CB2 Insights Inc. (the ?Corporation?), of proxies for the a |
|
| May 6, 2021 |
Table of Contents As filed with the Securities and Exchange Commission on May 6, 2021 Registration No. |
|
| May 6, 2021 |
Exhibit 4.1 Annual Information Form SKYLIGHT HEALTH GROUP INC. For the year ended December 31, 2020 Dated as of April 19, 2021 TABLE OF CONTENTS PRELIMINARY NOTES 1 FORWARD-LOOKING INFORMATION 1 NON-IFRS MEASURES 2 CORPORATE STRUCTURE 2 GENERAL DEVELOPMENT OF THE BUSINESS 3 DESCRIPTION OF THE BUSINESS 10 RISK FACTORS 13 DIVIDENDS 21 DESCRIPTION OF CAPITAL STRUCTURE 21 MARKET FOR SECURITIES 21 ESCR |
|
| May 6, 2021 |
Exhibit 4.6 SKYLIGHT HEALTH GROUP INC. 5045 Orbitor Drive, Building 11, Unit 300 Mississauga, Ontario, L4W 4Y4 NOTICE OF SPECIAL MEETING NOTICE IS HEREBY GIVEN THAT a special meeting of the shareholders of Skylight Health Group Inc. (the ?Corporation?) will be held virtually through the platform of AGM Connect to facilitate an interactive meeting and live online voting for Registered shareholders |
|
| May 6, 2021 |
Exhibit 4.9 FORM 51-102F3 MATERIAL CHANGE REPORT UNDER NATIONAL INSTRUMENT 51-102 1. Name and Address of Company Skylight Health Group Inc. (the ?Company?) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 2. Date of Material Change March 16, 2021 3. News Release A news release with respect to the material change referred to in this report was disseminated through Globe News Wire on Marc |
|
| May 6, 2021 |
Exhibit 4.3 MANAGEMENT?S DISCUSSION AND ANALYSIS For the Years Ended December 31, 2020 and 2019 (Expressed in Canadian Dollars, unless otherwise stated) April 19, 2021 Skylight Health Group Inc (formerly CB2 Insights Inc) Management Discussion and Analysis For the years ended December 31, 2020 and 2019 Introduction The following management?s discussion and analysis (?MD&A?) of the financial condit |
|
| May 6, 2021 |
Exhibit 4.2 Skylight Health Group Inc. (formerly CB2 Insights Inc.) Audited Consolidated Financial Statements For the years ended December 31, 2020 and 2019. (Expressed in Canadian Dollars) SKYLIGHT HEALTH GROUP INC. (formerly CB2 Insights Inc.) CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2020 AND 2019 Management?s Responsibility for Consolidated Financial Reporting 1 Independent Auditor?s Repo |
|
| May 6, 2021 |
Exhibit 4.5 CB2 INSIGHTS INC. 5045 Orbitor Drive, Building 11, Unit 300 Mississauga, Ontario, L4W 4Y4 MANAGEMENT INFORMATION CIRCULAR FOR THE SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON NOVEMBER 23, 2020 This management information circular (this ?Circular?) is being furnished in connection with the solicitation, by management of CB2 Insights Inc. (the ?Corporation?), of proxies for the special |
|
| May 6, 2021 |
Exhibit 4.7 FORM 51-102F3 MATERIAL CHANGE REPORT UNDER NATIONAL INSTRUMENT 51-102 1. Name and Address of Company Skylight Health Group Inc. (the ?Company?) 5045 Orbitor Drive, Building 11, Unit 300 Mississauga, Ontario, L4W 4Y4 2. Date of Material Change January 7, 2021 3. News Release A news release with respect to the material change referred to in this report was disseminated through Globe News |
|
| April 22, 2021 |
Exhibit 4.2 Skylight Health Group Inc. (formerly CB2 Insights Inc.) Audited Consolidated Financial Statements For the years ended December 31, 2020 and 2019. (Expressed in Canadian Dollars) SKYLIGHT HEALTH GROUP INC. (formerly CB2 Insights Inc.) CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2020 AND 2019 Management?s Responsibility for Consolidated Financial Reporting 1 Independent Auditor?s Repo |
|
| April 22, 2021 |
Exhibit 4.4 CB2 INSIGHTS INC. 5045 Orbitor Drive, Building 11, Unit 300 Mississauga, Ontario, L4W 4Y4 MANAGEMENT INFORMATION CIRCULAR FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON SEPTEMBER 9, 2020 This management information circular (this ?Circular?) is being furnished in connection with the solicitation, by management of CB2 Insights Inc. (the ?Corporation?), of proxies for the a |
|
| April 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM F-X APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING A. |
|
| April 22, 2021 |
Table of Contents As filed with the Securities and Exchange Commission on April 22, 2021 Registration No. |
|
| April 22, 2021 |
14, 2021 in respect of the announcement of the appointment of Grace Mellis as a director; Exhibit 4.8 FORM 51-102F3 MATERIAL CHANGE REPORT UNDER NATIONAL INSTRUMENT 51-102 1. Name and Address of Company Skylight Health Group Inc. (the ?Company?) 5045 Orbitor Drive, Building 11, Unit 300 Mississauga, Ontario, L4W 4Y4 2. Date of Material Change January 14, 2021 3. News Release A news release with respect to the material change referred to in this report was disseminated through Globe New |
|
| April 22, 2021 |
24, 2021 in respect of the announcement of the appointment of Patrick McNamee as a director; Exhibit 4.9 FORM 51-102F3 MATERIAL CHANGE REPORT UNDER NATIONAL INSTRUMENT 51-102 1. Name and Address of Company Skylight Health Group Inc. (the ?Company?) 5520 Explorer Drive, Suite 402 Mississauga, Ontario L4W 5L1 2. Date of Material Change March 16, 2021 3. News Release A news release with respect to the material change referred to in this report was disseminated through Globe News Wire on Marc |
|
| April 22, 2021 |
Management’s Discussion and Analysis for the fiscal year ended December 31, 2020 Exhibit 4.3 MANAGEMENT?S DISCUSSION AND ANALYSIS For the Years Ended December 31, 2020 and 2019 (Expressed in Canadian Dollars, unless otherwise stated) April 19, 2021 Skylight Health Group Inc (formerly CB2 Insights Inc) Management Discussion and Analysis For the years ended December 31, 2020 and 2019 Introduction The following management?s discussion and analysis (?MD&A?) of the financial condit |
|
| April 22, 2021 |
Exhibit 4.1 Annual Information Form SKYLIGHT HEALTH GROUP INC. For the year ended December 31, 2020 Dated as of April 19, 2021 TABLE OF CONTENTS PRELIMINARY NOTES 1 FORWARD-LOOKING INFORMATION 1 NON-IFRS MEASURES 2 CORPORATE STRUCTURE 2 GENERAL DEVELOPMENT OF THE BUSINESS 3 DESCRIPTION OF THE BUSINESS 10 RISK FACTORS 13 DIVIDENDS 21 DESCRIPTION OF CAPITAL STRUCTURE 21 MARKET FOR SECURITIES 21 ESCR |
|
| April 22, 2021 |
Exhibit 4.6 SKYLIGHT HEALTH GROUP INC. 5045 Orbitor Drive, Building 11, Unit 300 Mississauga, Ontario, L4W 4Y4 NOTICE OF SPECIAL MEETING NOTICE IS HEREBY GIVEN THAT a special meeting of the shareholders of Skylight Health Group Inc. (the ?Corporation?) will be held virtually through the platform of AGM Connect to facilitate an interactive meeting and live online voting for Registered shareholders |
|
| April 22, 2021 |
Exhibit 4.5 CB2 INSIGHTS INC. 5045 Orbitor Drive, Building 11, Unit 300 Mississauga, Ontario, L4W 4Y4 MANAGEMENT INFORMATION CIRCULAR FOR THE SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON NOVEMBER 23, 2020 This management information circular (this ?Circular?) is being furnished in connection with the solicitation, by management of CB2 Insights Inc. (the ?Corporation?), of proxies for the special |
|
| April 22, 2021 |
Exhibit 4.7 FORM 51-102F3 MATERIAL CHANGE REPORT UNDER NATIONAL INSTRUMENT 51-102 1. Name and Address of Company Skylight Health Group Inc. (the ?Company?) 5045 Orbitor Drive, Building 11, Unit 300 Mississauga, Ontario, L4W 4Y4 2. Date of Material Change January 7, 2021 3. News Release A news release with respect to the material change referred to in this report was disseminated through Globe News |
